Inventor
PATEL NANDINI CHATURBHAI
US16 patents
⚠️ This page may combine multiple inventors who share the name “PATEL NANDINI CHATURBHAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
15 patentsUS9598421B2Mar 21, 2017
Imidazopyridazine compounds
PFIZER6 citations83
US9120788B2Sep 1, 2015
Azabenzimidazole compounds
PFIZER8 citations83
US8916564B2Dec 23, 2014
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
PFIZER6 citations82
US10738063B2Aug 11, 2020
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
PFIZER3 citations72
US9815832B2Nov 14, 2017
Azabenzimidazole compounds
PFIZER4 citations72
US11472805B2Oct 18, 2022
Tricyclic compounds and their use as phosphodiesterase inhibitors
PFIZER4 citations71
US10323042B2Jun 18, 2019
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
PFIZER1 citations62
US12049465B2Jul 30, 2024
Tricyclic compounds and their use as phosphodiesterase inhibitors
PFIZER0 citations60
US11390623B2Jul 19, 2022
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands
PFIZER0 citations60
US9751877B2Sep 5, 2017
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
PFIZER1 citations60
US10669279B2Jun 2, 2020
Imidazopyridazine compounds
PFIZER0 citations51
US10077269B2Sep 18, 2018
Imidazopyridazine compounds
PFIZER1 citations51
US9193726B2Nov 24, 2015
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
PFIZER1 citations50
US10590128B2Mar 17, 2020
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands
PFIZER0 citations49
US10131669B2Nov 20, 2018
Pyrazolopyrimidine compounds
PFIZER0 citations41